Posted on April 18, 2018 by Sitemaster
One of the critical and unanswered questions about the value of genomic/genetic testing in relation to the diagnosis and prognosis of prostate cancer is, “What are the currently available tests actually telling us compared to the clinical data?” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Diagnosis, genetic, genomic, prognosis, risk, test | 2 Comments »
Posted on March 26, 2018 by Sitemaster
In an important decision announced late on Friday last week, the Centers for Medicare & Medicaid Services (CMS) announced that it had agreed to cover costs associated with genetic/genomic testing for Medicare patients with many advanced forms of cancer. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: approval, coverage, genetic, genomic, next generation, NGS, sequencing, test | 1 Comment »
Posted on February 27, 2018 by Sitemaster
Over the past few years, with the increased focus on the idea of “personalized” medicine, we have become increasingly informed about and focused on correlations between genetics and genomics and risk for prostate cancer. However, … READ MORE …
Filed under: Diagnosis, Risk | Tagged: familial, genetic, grandsons, hereditary, risk, sons | 4 Comments »
Posted on February 22, 2018 by Sitemaster
Yesterday evening we were pleased to be able to collaborate with CureTalks to host a conversation with Dr. Eli Van Allen — the principal investigator for the Metastatic Prostate Cancer Project — to “spread the word” about this initiative. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: advanced, database, genetic, genomic, metastatic | Leave a comment »
Posted on February 15, 2018 by Sitemaster
On Wednesday, February 21, at 5:00 p.m. Eastern time (2:00 p.m. Pacific), we will be collaborating with CureTalks to present the next CureTalk on prostate cancer. It will address the recently launched “Metastatic Prostate Cancer Project”. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: advanced, CureTalk, database, genetic, genomic, metastatic | Leave a comment »
Posted on February 2, 2018 by Sitemaster
There’s a very nice article today on the MedPage Today web site about the medical value of “at-home genetic testing” (i.e., the sorts of tests available from companies like 23&Me and some others). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: genetic, test, utility, value | 3 Comments »
Posted on January 13, 2018 by Sitemaster
Data from a new study reported in the British Medical Journal discusses a “polygenic hazard score” that can potentially be used to guide screening for aggressive prostate cancer (but only in men of European ancestry at this time). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aggressive, data, genetic, genomic, predict, risk, testing | 2 Comments »
